|
Volumn 46, Issue 6, 2002, Pages 1870-1874
|
Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
HYDROCORTISONE;
ME 609;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREAM;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG POTENTIATION;
HEALING;
HERPES LABIALIS;
HUMAN;
IMMUNOCOMPETENCE;
IMMUNOMODULATION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RADIATION INJURY;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
ACYCLOVIR;
ADMINISTRATION, TOPICAL;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-INFLAMMATORY AGENTS;
ANTIVIRAL AGENTS;
DOUBLE-BLIND METHOD;
DRUG COMBINATIONS;
FEMALE;
HERPES LABIALIS;
HUMANS;
HYDROCORTISONE;
MALE;
MIDDLE AGED;
OINTMENTS;
RECURRENCE;
ULTRAVIOLET RAYS;
|
EID: 0036096362
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.46.6.1870-1874.2002 Document Type: Article |
Times cited : (62)
|
References (11)
|